A crystalline form of (S)-2-((3-((benzo[d][1,3]dioxol-5-yl)methyl)benzyl)- amino)propanamide
By preparing multiple crystal forms of (S)-2-((3-((benzo[d][1,3]dioxopenta-5-oxo)methyl)benzyl)-amino)propionamide, the problems of water solubility, hygroscopicity and stability of the compound were solved, and its drugability as a drug was improved, especially for the treatment of neuropathic pain.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ACADEMY OF MILITARY MEDICAL SCIENCES
- Filing Date
- 2026-04-03
- Publication Date
- 2026-06-02
AI Technical Summary
Existing (S)-2-((3-((benzo[d][1,3]dioxopentane-5-oxo)methyl)benzyl)-amino)propionamide compounds suffer from poor water solubility, high hygroscopicity, and poor stability, which affect their drug-like properties as drug molecules.
Multiple crystal forms A, B, C, D, E, F, and G were developed. Through reactions of different acids with free bases, compound crystal forms with high solubility, low hygroscopicity, excellent stability, and improved bioavailability were prepared.
This study achieves high solubility, low hygroscopicity, excellent stability, and improved bioavailability of the compound, making it suitable for drug preparation and applicable to the treatment of neuropathic pain.
Smart Images

Figure CN122127303A_ABST
Abstract
Citation Information
Patent Citations
Compound with analgesic activity, and pharmaceutical applications thereof
CN104761531A